Preliminary experience of single operative port thoracoscopic anatomical lesion resection for congenital lung malformations in segments S9-10

单孔胸腔镜解剖性病变切除术治疗S9-10段先天性肺畸形的初步经验

阅读:1

Abstract

PURPOSE: To compare the clinical outcomes of single operative port thoracoscopic anatomical lesion resection (TALR) with multi-portal video-assisted thoracic surgery (M-VATS) in the treatment of congenital lung malformations (CLMs) located in pulmonary segments S9-10, and to evaluate its safety and feasibility in routine practice. METHODS: We retrospectively analysed 46 paediatric CLMs cases treated thoracoscopically at our institution from January 2023 to January 2025. Patients were grouped by surgical approach: 13 underwent single operative port TALR, and 33 underwent M-VATS. Clinical parameters were compared between groups. RESULTS: Compared to M-VATS, the single operative port TALR showed significantly reduced blood loss (P = 0.01), chest tube time (P = 0.04), hospital stays (P = 0.04), and incision length (P < 0.01). No bronchopleural fistulas, conversions to open surgery, no recurrence or residual lesions occurred in either group. CONCLUSION: single operative port TALR is safe, feasible, minimally invasive, and offers excellent cosmetic outcomes, representing a promising surgical technique for treating CLMs involving segments S9-10.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。